BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27118620)

  • 1. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial.
    Kario K; Bhatt DL; Kandzari DE; Brar S; Flack JM; Gilbert C; Oparil S; Robbins M; Townsend RR; Bakris G
    Circ J; 2016 May; 80(6):1404-12. PubMed ID: 27118620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry.
    Linz D; Mancia G; Mahfoud F; Narkiewicz K; Ruilope L; Schlaich M; Kindermann I; Schmieder RE; Ewen S; Williams B; Böhm M;
    J Hypertens; 2017 Jan; 35(1):148-153. PubMed ID: 27906840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial.
    Warchol-Celinska E; Prejbisz A; Kadziela J; Florczak E; Januszewicz M; Michalowska I; Dobrowolski P; Kabat M; Sliwinski P; Klisiewicz A; Topor-Madry R; Narkiewicz K; Somers VK; Sobotka PA; Witkowski A; Januszewicz A
    Hypertension; 2018 Aug; 72(2):381-390. PubMed ID: 29941516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
    Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
    Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
    Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
    Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
    Böhm M; Tsioufis K; Kandzari DE; Kario K; Weber MA; Schmieder RE; Townsend RR; Kulenthiran S; Ukena C; Pocock S; Ewen S; Weil J; Fahy M; Mahfoud F
    J Am Coll Cardiol; 2021 Sep; 78(10):1028-1038. PubMed ID: 34474735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.
    Muxfeldt ES; Margallo V; Costa LM; Guimarães G; Cavalcante AH; Azevedo JC; de Souza F; Cardoso CR; Salles GF
    Hypertension; 2015 Apr; 65(4):736-42. PubMed ID: 25601933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renal sympathetic denervation on blood pressure, sleep apnoea severity and metabolic indices: a prospective cohort study.
    Daniels F; De Freitas S; Smyth A; Garvey J; Judge C; Gilmartin JJ; Sharif F
    Sleep Med; 2017 Feb; 30():180-184. PubMed ID: 28215245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial).
    Peters CD; Mathiassen ON; Vase H; Bech Nørgaard J; Christensen KL; Schroeder AP; Rickers HJVH; Opstrup UK; Poulsen PL; Langfeldt S; Andersen G; Hansen KW; Bøtker HE; Engholm M; Bertelsen JB; Pedersen EB; Kaltoft A; Buus NH
    Blood Press; 2017 Dec; 26(6):366-380. PubMed ID: 28830251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
    Esler MD; Böhm M; Sievert H; Rump CL; Schmieder RE; Krum H; Mahfoud F; Schlaich MP
    Eur Heart J; 2014 Jul; 35(26):1752-9. PubMed ID: 24898552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive Sleep Apnea-Induced Neurogenic Nocturnal Hypertension: A Potential Role of Renal Denervation?
    Kario K; Hettrick DA; Prejbisz A; Januszewicz A
    Hypertension; 2021 Apr; 77(4):1047-1060. PubMed ID: 33641363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial.
    Pedrosa RP; Drager LF; de Paula LKG; Amaro ACS; Bortolotto LA; Lorenzi-Filho G
    Chest; 2013 Nov; 144(5):1487-1494. PubMed ID: 23598607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
    Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
    Linz D; Mahfoud F; Linz B; Hohl M; Schirmer SH; Wirth KJ; Böhm M
    Am J Hypertens; 2014 Oct; 27(10):1293-300. PubMed ID: 24622919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.